To allow for the possibility to test anti-HER2 IgE in a corresponding rat breast cancer model, the sequential phage display panning approach was adopted to enrich for antibodies exhibiting cross-reactivity to rHER2 (Fig. 1A). This evidence concerns the gene ERBB2 and breast carcinoma.